Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.20    2.00 (1.94%)
Bid:
104.40
Ask:
105.20
Spread: 0.80 (0.766%)
Market Cap: £172.47m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

1 May 2014 07:00

RNS Number : 0132G
Synthomer PLC
01 May 2014
Β 

ο»Ώ

1st May 2014

Β 

Synthomer plc

Β 

AGM and Interim Management Statement

Β 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 January to 30 April 2014.

Β 

Trading

Β 

We reported with our full year results in February that we had experienced slightly firmer demand in Europe across our Construction & Coatings, Functional Polymers and Performance Polymers segments. Encouragingly, this trend has continued, and as a result operating profit for the first quarter in our Europe and North America business (ENA) was ahead of the prior year, despite an adverse currency translation impact of Β£0.6M.

Β 

In our Asia and Rest of the World (ARW) business, volumes have continued to progress. However, recent substantial expansions by nitrile customers has led to excess glove capacity and aggressive competition between glove manufacturers. Combined with falling Butadiene prices this has resulted in destocking and short term pressure on nitrile margins. However, we expect on-going demand growth for nitrile latex and unit margins to firm as the year progresses.

Β 

The Group is currently developing plans for a further expansion of nitrile latex capacity, and expects to make an announcement in the next few months

Β 

Financial Position

Β 

Net debt increased over the first three months in line with normal seasonality. The Board has previously indicated it would move dividend cover to three times by 2015. However, in the light of the Group's current low leverage, and strong underlying cash flow generation, the Board is reviewing that policy with a view to increasing the planned level of returns to shareholders. Any revised dividend policy will be formally communicated to shareholders with the interim results.

Β 

Outlook

Whilst the start to the year in Europe has been encouraging, we remain cautious until these trends become more sustained. So far in 2014, Asia has performed below our expectations due to the competitive environment in the glove market. Although the overall Asia and ROW results may now be slightly weaker than our expectations at the start of the year, we believe the fundamental drivers for our business in the region remain strong.

Β 

The Board remains confident in the medium and long term outlook for the Group.

Β 

Synthomer will announce its Interim Results on Monday 11th August 2014.

Β 

Enquiries:

Β 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rosie Oddy

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

The company will host a conference call for analysts at 8.00am (BST) today:

Β 

Dial-In: +44 203 426 2845Β 

Please quoteΒ "Synthomer" to gain access to the call

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSURAORSVASOUR
Date   Source Headline
17th May 20077:01 amRNSAGM Statement
15th May 20074:29 pmRNSAnnual Report and Accounts
20th Apr 20079:40 amRNSAnnual Information Update
19th Apr 200712:47 pmRNSHolding(s) in Company
10th Apr 20075:26 pmRNSDirectorate Change
29th Mar 20074:37 pmRNSHolding(s) in Company
22nd Mar 200712:30 pmRNSDirectorate Change
12th Mar 20071:05 pmRNSDirector/PDMR Shareholding
12th Mar 20071:00 pmRNSDirector/PDMR Shareholding
7th Mar 20077:01 amRNSFinal Results
6th Mar 20074:04 pmRNSHolding(s) in Company
20th Feb 20074:29 pmRNSNotice of Results
1st Feb 20074:23 pmRNSBlocklisting Interim Review
18th Dec 20062:08 pmRNSVoting Rights and Capital
15th Dec 20067:58 amRNSTrading Statement
4th Dec 200612:49 pmRNSBlocklisting Interim Review
12th Oct 200610:46 amRNSHolding(s) in Company
2nd Oct 20063:20 pmRNSDirector/PDMR Shareholding
8th Sep 20069:01 amRNSDirector/PDMR Shareholding
7th Sep 20067:01 amRNSInterim Results
21st Aug 20063:22 pmRNSNotice of Results
21st Aug 20062:41 pmRNSDirectorate Change
1st Aug 20062:51 pmRNSBlocklisting Interim Review
14th Jul 20063:51 pmRNSNew Chief Executive
7th Jun 200611:14 amRNSDirector/PDMR Shareholding
5th Jun 20067:00 amRNSDisposal of Reabrook Limited
1st Jun 20064:48 pmRNSBlocklisting Interim Review
25th May 20063:11 pmRNSDirector/PDMR Shareholding
25th May 20063:09 pmRNSDirector/PDMR Shareholding
18th May 20064:59 pmRNSResult of AGM
18th May 200612:00 pmRNSAGM Statement
3rd May 200612:28 pmRNSAnnual Information Update
18th Apr 20063:49 pmRNSAnnual Report and Accounts
13th Apr 200611:30 amRNSDirector/PDMR Shareholding
13th Apr 200611:28 amRNSDirector/PDMR Shareholding
21st Mar 200612:05 pmRNSDirector/PDMR Shareholding
16th Mar 20067:01 amRNSFinal Results
20th Feb 20063:44 pmRNSHolding(s) in Company
20th Feb 20062:00 pmRNSAppointment
9th Feb 200612:10 pmRNSNotice of Results
31st Jan 200610:00 amRNSAdditional Listing
30th Dec 200512:00 pmRNSWithdrawal from SO2 business
23rd Dec 200510:14 amRNSDirector/PDMR Shareholding
14th Dec 20057:00 amRNSPre-close Trading Statement
8th Dec 20051:29 pmRNSBlocklisting Interim Review
7th Dec 20058:42 amRNSSale of Autoclenz Limited
7th Dec 20057:01 amRNSAdmission to trading on AIM
6th Dec 20054:23 pmRNSDirector Declaration
6th Dec 20054:18 pmRNSDirectorate Change
2nd Dec 200510:07 amRNSSale of Autoclenz Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.